| |
| |
|
|
|
Snow
& Ice Driving Experience
On the Friday morning before the conference, we
are organising a snow and ice driving experience
for those looking to brush up on their winter
driving skills. Located one hour from Queenstown
is the only testing facility in the sothern hemisphere
used by European car manufacturers to test their
vehicles in icy conditions.

In this half
day group booking, you will drive a range of European
cars in groomed ice and snow tracks under the
guidance of experienced instructors. A bus will
leave Queenstown at 7am on Friday morning and
get you back to the conference facility at 12.30pm,
just in time for the conference kick off.
The approximate cost of this activity will be
around A$400 each. If you are interested in participating
please let us know. Expressions of interest only
at this stage with minimum numbers required.
Details of the facility can be viewed
here.
|
|
Bioshares
Biotech Summit 2011
The 7th Bioshares Biotech Summit is being held on Friday
22 - Saturday 23 July, 2011. The conference is organised
by Bioshares, Australia's leading independent biotech
investment publication. The conference is being held
with the support of New Zealand Trade &
Enterprise.
A
conference program will be released in May. Once again
it will be packed with around 10 hours of stimulating
conference sessions to discuss the key themes of Australian
biotech and to hear from some of Australia's leading
and most exciting biotech companies. The Conference
Program is now available.
Registration
- Now Open!
Registration for this event is now open. Click here
to download a Registration
Form
Getting to Queenstown
Queenstown is a picturesque town located in the south
island of New Zealand. For Australian delegates, direct
flights are available from the east coast of Australia
to Queenstown in July, with Air New Zealand, Virgin
(Pacific Blue) and Qantas all servicing this route,
however direct flight options are not daily. (Check
Air New Zealand for special offers).
Once you fly into Queenstown, we are seeking to organise
Jet Boat Taxis (approximate price $60)
to Rydges Hotel. If you are interested please let us
know. This service will only be available if we have
sufficient numbers on the same flight so you will need
to send us your travel details.
Current taxis
are available at:
Thursday 21 July, 2pm (flight arrival)
Thursday 21 July, 3.30pm (flight arrival)
Accommodation
We have arranged accommodation packages at the conference
facility, the Rydges Lakeland Resort, where delegates
can secure accommodation at a discounted rate of NZ$175
per night for a twin/double room, for the week of the
conference. There are several rooms available (as of
9 June 2011). Call Rydges reservations on +64 3 442
7600.
Other accommodations include Peppers
(+64 3 441 0890) larger apartments next to Rydges and
the St
Moritz Hotel (+64 3 442 4990) also close to the
conference venue.
Conference Sessions &
Social functions
Official conference sessions will commence on Friday
22 July and conclude on Saturday 23 July. There will
be dinner functions on the Friday and Saturday evenings,
as well as informal pre-conference drinks on the Thursday
evening, 21 July. We recommend delegates arrive early
or stay on after the conference to enjoy some of the
spectacular attractions of Queenstown.
We look forward to seeing you at
Queenstown! If you have any queries, please contact
the Bioshares office on (03) 9348 9317or by email.
The Editors
Bioshares

|
Confirmed
Speakers & Panelists
......include.... |
|
Silviu Itescu
CEO, Mesoblast
|
| Richard
Treagus
CEO of Acrux |
Paul Wright
CEO, Universal Biosensors
|
| Damian
Lismore
CFO of Biota Holdings |
|
Graeme McRae
CEO, Bioniche
|
| Esra
Ogru, CEO of Phosphagenics
&
Paul Gavin, Phosphagenics |
| Paul
Ashton
CEO, Psivida |
| Geoff
Brooke
GBS Venture Partners |
| Paul
MacLeman
CEO, Genetic Technologies
|
| Bob
More
Frazier Healthcare Ventures |
|
Janette
Dixon
QRxPharma
|
| Mike
Hirshorn
Four Hats Capital
|
| Rudi
Michelson
Monsoon Communications
|
| Martyn
Myer
Chariman, Cogstate
|
| Larry
Glass
CEO of Neuren Pharmaceuticals |
| Nick
Woolf
Phylogica
|
| Alan
Liddle
CEO, Immune System Therapeutics
|
| Simon
Wilkinson
CEO of Innate Therapeutics |
Andrew
Maxwell
Global Kinetics Corporation
|
Greg
Moss-Smith
CEO of Photonz
|
| Cliff
Holloway
CEO of Biosceptre |
Brian Ward
CEo of Mesynthes
|
| Mark
Pachacz
Bioshares |
|
| |
|
|
|